121 related articles for article (PubMed ID: 22036089)
21. A novel method for detection of mutation in epidermal growth factor receptor.
Zhao J; Zhao J; Huang J; Chen Y; Jiang J; Wu W; Wang P; Liu L; Li L; Wu L; Wang M; Chen W
Lung Cancer; 2011 Nov; 74(2):226-32. PubMed ID: 21439672
[TBL] [Abstract][Full Text] [Related]
22. [Is lung cancer in women different?].
Ben Aissa A; Mach N
Rev Med Suisse; 2012 May; 8(342):1108-11. PubMed ID: 22734179
[TBL] [Abstract][Full Text] [Related]
23. EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study.
Han B; Tjulandin S; Hagiwara K; Normanno N; Wulandari L; Laktionov K; Hudoyo A; He Y; Zhang YP; Wang MZ; Liu CY; Ratcliffe M; McCormack R; Reck M
Lung Cancer; 2017 Nov; 113():37-44. PubMed ID: 29110846
[TBL] [Abstract][Full Text] [Related]
24. Sample features associated with success rates in population-based EGFR mutation testing.
Shiau CJ; Babwah JP; da Cunha Santos G; Sykes JR; Boerner SL; Geddie WR; Leighl NB; Wei C; Kamel-Reid S; Hwang DM; Tsao MS
J Thorac Oncol; 2014 Jul; 9(7):947-956. PubMed ID: 24922009
[TBL] [Abstract][Full Text] [Related]
25. Molecular diagnostic profiling of lung cancer specimens with a semiconductor-based massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing.
Endris V; Penzel R; Warth A; Muckenhuber A; Schirmacher P; Stenzinger A; Weichert W
J Mol Diagn; 2013 Nov; 15(6):765-75. PubMed ID: 23973117
[TBL] [Abstract][Full Text] [Related]
26. Fully automated real-time PCR for EGFR testing in non-small cell lung carcinoma.
Colling R; Bancroft H; Langman G; Soilleux E
Virchows Arch; 2019 Feb; 474(2):187-192. PubMed ID: 30470932
[TBL] [Abstract][Full Text] [Related]
27. A proposal for cellularity assessment for EGFR mutational analysis with a correlation with DNA yield and evaluation of the number of sections obtained from cell blocks for immunohistochemistry in non-small cell lung carcinoma.
da Cunha Santos G; Wyeth T; Reid A; Saieg MA; Pitcher B; Pintilie M; Kamel-Reid S; Tsao MS
J Clin Pathol; 2016 Jul; 69(7):607-11. PubMed ID: 26733659
[TBL] [Abstract][Full Text] [Related]
28. EGFR mutation testing of lung cancer patients - Experiences from Vestfold Hospital Trust.
Berg J; Fjellbirkeland L; Suhrke P; Jebsen P; Lund-Iversen M; Kleinberg L; Helgeland L; Brustugun OT; Helland Å
Acta Oncol; 2016; 55(2):149-55. PubMed ID: 26313507
[TBL] [Abstract][Full Text] [Related]
29. Preanalytic parameters in epidermal growth factor receptor mutation testing for non-small cell lung carcinoma: A review of cytologic series.
da Cunha Santos G; Saieg MA
Cancer Cytopathol; 2015 Nov; 123(11):633-43. PubMed ID: 26288231
[TBL] [Abstract][Full Text] [Related]
30. Clinicians' views on introducing epidermal growth factor receptor testing in New Zealand.
Batten LS; Winter HS; Hardie CL; Holdaway MA
Asia Pac J Clin Oncol; 2013 Sep; 9(3):249-56. PubMed ID: 23057561
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of the Relationship Between the Quality of Small Biopsy Specimens of
Non-small Cell Lung Cancer and the Mutation Rate of EGFR Gene].
Li Y; Gu Y; Jiang J
Zhongguo Fei Ai Za Zhi; 2021 May; 24(5):331-337. PubMed ID: 34034456
[TBL] [Abstract][Full Text] [Related]
32. Idylla
Khalifa E; Chapusot C; Tournier B; Sentis J; Marion E; Remond A; Aubry M; Pioche C; Bergeron A; Primois C; Blanchard L; Millière A; Boucheix M; Léger Y; Bairrao M; Brouste V; Martin L; Soubeyran I
J Clin Pathol; 2023 Oct; 76(10):698-704. PubMed ID: 35820776
[TBL] [Abstract][Full Text] [Related]
33. Epidermal growth factor receptor mutations in East European non-small cell lung cancer patients.
Bichev SN; Marinova DM; Slavova YG; Savov AS
Cell Oncol (Dordr); 2015 Apr; 38(2):145-53. PubMed ID: 25534657
[TBL] [Abstract][Full Text] [Related]
34. An alternative approach to determining therapeutic choices in advanced non-small cell lung carcinoma (NSCLC): maximizing the diagnostic procedure and the use of low-volume lung biopsies.
Lim EH; Zhang SL; Yu K; Nga ME; Ahmed DA; Agasthian T; Wong PS; Chua GC; Wong D; Tan L; Seto KY; Yap WS; Low SP; Khoo KL; Chang A; Ng A; Tan P
J Thorac Oncol; 2007 May; 2(5):387-96. PubMed ID: 17473653
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Confirmed Cytology Smears and Cell Blocks for Epidermal Growth Factor Receptor Mutation Testing in Non-Small Cell Lung Cancer.
Liu CH; Chang SJ; Tsai MJ; Yang SF
Appl Immunohistochem Mol Morphol; 2023 Nov-Dec 01; 31(10):701-706. PubMed ID: 37807651
[TBL] [Abstract][Full Text] [Related]
36. Improvement in the quality of molecular analysis of EGFR in non-small-cell lung cancer detected by three rounds of external quality assessment.
Deans ZC; Bilbe N; O'Sullivan B; Lazarou LP; de Castro DG; Parry S; Dodson A; Taniere P; Clark C; Butler R
J Clin Pathol; 2013 Apr; 66(4):319-25. PubMed ID: 23378269
[TBL] [Abstract][Full Text] [Related]
37. EGFR MUTATIONS IN NON-SMALL CELL LUNG CANCER: LOCAL EPIDEMIOLOGY AND CLINICAL IMPORTANCE.
Rusu-Cordunean F; Berlea ML; Cernomaz AT; Marinca MV; Peter S; Pavel I; Grigoriu BD
Rev Med Chir Soc Med Nat Iasi; 2015; 119(4):1031-6. PubMed ID: 26793845
[TBL] [Abstract][Full Text] [Related]
38. EGFR analysis: current evidence and future directions.
Bellevicine C; Malapelle U; de Luca C; Iaccarino A; Troncone G
Diagn Cytopathol; 2014 Nov; 42(11):984-92. PubMed ID: 24619906
[TBL] [Abstract][Full Text] [Related]
39. Molecular Testing Turnaround Time for Non-Small Cell Lung Cancer in Routine Clinical Practice Confirms Feasibility of CAP/IASLC/AMP Guideline Recommendations: A Single-center Analysis.
DiStasio M; Chen Y; Rangachari D; Costa DB; Heher YK; VanderLaan PA
Clin Lung Cancer; 2017 Sep; 18(5):e349-e356. PubMed ID: 28377205
[TBL] [Abstract][Full Text] [Related]
40. Is the Idylla
De Luca C; Conticelli F; Leone A; Gragnano G; Salatiello M; Galasso P; Pisapia P; Grillo LR; Iaccarino A; Vigliar E; Bellevicine C; Malapelle U; Troncone G
J Clin Pathol; 2019 Sep; 72(9):609-614. PubMed ID: 31110050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
